Sponsors (5)
Introduced August 12, 2025 by Frank Pallone · Last progress August 12, 2025
The bill strengthens FDA oversight, transparency, and funding for GRAS/substance reviews—improving consumer safety—but does so by imposing substantial new testing, fee, and compliance burdens that could raise costs for manufacturers and consumers and create short-term regulatory transition risks.
Consumers: stronger FDA authority and routine reassessments mean unsafe or poorly evaluated GRAS substances are more likely to be identified and removed or limited, reducing exposure to harmful food additives.
Consumers and the public: increased transparency — mandated public access to safety data, required postings of revocations/notifications, and a 60-day public comment window for new GRAS uses — gives consumers and stakeholders better information and oversight.
Manufacturers and the public: statutory decision timelines (FDA required to act within 180 days, with one 90-day extension) and clearer regulatory definitions speed decisionmaking and provide more predictable regulatory clarity.
Manufacturers (especially small businesses): substantially higher compliance costs — more rigorous studies, expanded safety evaluations every 3 years, and required detailed GRAS notices — will raise business costs and regulatory burden.
Consumers and taxpayers: higher industry costs and new full-cost user fees may be passed through to consumers as higher food prices, disproportionately affecting low-income households.
Manufacturers and consumers: stricter review, longer evidence requirements, and the possibility of FDA revoking prior no-objections can slow the introduction of new ingredients and disrupt product availability or force reformulation.
Based on analysis of 6 sections of legislative text.
Removes the GRAS exemption, creates mandatory GRAS notices and public review, requires routine FDA reassessments, expands definitions, and imposes fees to fund reviews.
Changes how the law treats substances added to food by removing the long-standing "GRAS" (generally recognized as safe) exemption from the food additive definition and setting up a mandatory FDA notice and review system for GRAS determinations. Food companies would have to notify FDA before treating a substance or new use as GRAS, FDA must publicly post notices and respond on a strict timeline, and the agency must systematically reassess certain classes of food substances every three years, with authority to revoke previous approvals. The bill also adds detailed statutory definitions, requires detailed safety data in notices, creates civil penalties for violations, and adds new fees to pay for FDA review and reassessment work (plus authorization for whatever sums are necessary).